Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results
BEIJING, Dec. 3, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial...
S3 Connected Health Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Medical Device Connectivity
Recognized for pioneering advancements that redefine medical device connectivity, accelerate home-based care, and deliver transformative value across global healthcare ecosystems. SAN ANTONIO, Dec. 3, 2025 /PRNewswire/ -- Frost & Sullivan is...
vHive Launches Real-Time Solution to Validate As-Built Installations for MNOs
NEW YORK, Dec. 3, 2025 /PRNewswire/ -- vHive, a global leader in infrastructure digitization, announces the launch of On-Site Validation, the first real-time field verification solution that ensures antenna installations match modification plans...
A New Chapter in Bilingual Excellence: YK Pao School Hong Kong Appoints its Founding Head
HONG KONG, Dec. 3, 2025 /PRNewswire/ -- In a significant milestone in its founding, YK Pao School Hong Kong today announces the appointment of Mrs. Cathy Braithwaite as its Founding Head. This appointment marks the next step in realising a visionary...
Beep Receives Frost & Sullivan's 2025 North American Technology Innovation Leadership Recognition for Excellence in Scalable, Service-Oriented Autonomous Mobility Solutions
Beep is honored for combining innovation, operational efficiency, and customer trust to advance autonomous shuttle adoption across public and private transit networks SAN ANTONIO, Dec. 3, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to...
Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®
FDA approval of OMLYCLO® (omalizumab-igec) 300 mg/2 mL solution in a single-dose prefilled syringe for subcutaneous injection expands dosing flexibility and supports tailored treatment for individual patients with certain allergic diseases OMLYCLO®...
Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities
SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and...
Cellid Announces Two New Reference Designs for Next-Generation AR Glasses
Cutting-edge wireless AR glasses enabled by proprietary optical technology and the latest waveguide innovations TOKYO, Dec. 2, 2025 /PRNewswire/ -- Cellid Inc., a developer of displays and spatial recognition engines for next-generation AR glasses,...
Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health
SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines...
TP Receives Frost & Sullivan's 2025 African Company of the Year Recognition for Excellence in the Outsourcing Industry
TP recognized for advancing Africa's outsourcing landscape through its strategic integration of technology, emotional intelligence, and sustainable growth initiatives. SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to...